Page last updated: 2024-12-06

3-amino-2-oxazolidinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

3-amino-2-oxazolidinone is a synthetic compound that has been studied for its potential therapeutic applications. It has been shown to exhibit antimicrobial activity against a range of bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The compound's mechanism of action is believed to involve inhibiting the synthesis of bacterial cell wall components. 3-amino-2-oxazolidinone has also been investigated for its potential as an anticancer agent, with studies suggesting that it may have activity against certain types of tumor cells. However, further research is needed to fully understand its therapeutic potential and safety profile.'
```

Cross-References

ID SourceID
PubMed CID65725
CHEBI ID173320
SCHEMBL ID1163805
MeSH IDM0040260

Synonyms (46)

Synonym
CHEBI:173320
nsc196570
nsc-196570
nsc38250
nsc-38250
3-aminooxazolidin-2-one
2-oxazolidinone, 3-amino-
3-amino-2-oxazolidone
nsc111187
80-65-9
3-amino-2-oxazolidinone
nsc-111187
3-amino-1,3-oxazolidin-2-one
inchi=1/c3h6n2o2/c4-5-1-2-7-3(5)6/h1-2,4h
FT-0661968
A839960
3-aminooxazolidin-2-id-4-one
einecs 201-299-2
nsc 111187
unii-vj7he86a15
vj7he86a15 ,
AKOS006228286
aoz ,
FT-0614939
S10190
3-amino oxazolidinone
SCHEMBL1163805
DTXSID00229996
3-amino-1,3-oxazolidin-2-one #
AC-33916
F9995-4179
aoz, vetranal(tm), analytical standard
AS-57894
3-amino-2-oxazolidinone (aoz)
3-amino-2-oxazolidinone aoz
mfcd00020871
BCP32566
CS-W013698
2-oxazolidinone, 3-amino-;3-amino-1,3-oxazolidin-2-one;3-aminooxazolidin-2-one
SY038618
A936035
HY-W012982
EN300-115889
3-amino-2-oxazolidinone (aoz) 100 microg/ml in acetonitrile
Z1198147716
1ST4201
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
oxazolidinoneAn oxazolidine containing one or more oxo groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (25.00)18.7374
1990's4 (11.11)18.2507
2000's10 (27.78)29.6817
2010's11 (30.56)24.3611
2020's2 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.15 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index4.71 (4.65)
Search Engine Demand Index30.68 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other45 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]